BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17143800)

  • 21. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
    Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
    Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.
    Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF
    Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical role of PUMA in maintenance of genomic integrity of murine spermatogonial stem cell precursors after genotoxic stress.
    Forand A; Bernardino-Sgherri J
    Cell Res; 2009 Aug; 19(8):1018-30. PubMed ID: 19417777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the potential mechanisms of leukemia cell resistance to TRAIL-induced apoptosis].
    Hao JH; Hao XS; Yu M; Shi YR; Yang Y
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):379-82. PubMed ID: 17147226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway.
    Ayed-Boussema I; Bouaziz C; Rjiba K; Valenti K; Laporte F; Bacha H; Hassen W
    Toxicol In Vitro; 2008 Oct; 22(7):1671-80. PubMed ID: 18662769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cells.
    Johnson AL; Ratajczak C; Haugen MJ; Liu HK; Woods DC
    Reproduction; 2007 Mar; 133(3):609-16. PubMed ID: 17379655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAIL-related neurotoxicity implies interaction with the Wnt pathway in human neuronal cells in vitro.
    Cantarella G; Di Benedetto G; Pezzino S; Risuglia N; Bernardini R
    J Neurochem; 2008 Jun; 105(5):1915-23. PubMed ID: 18266928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E; Vodjgani M; Massoud A; Keyhani A; Rajab A; Shafaghi B; Gheflati Z; Aboufazeli T
    Iran J Immunol; 2007 Dec; 4(4):197-205. PubMed ID: 18057577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death.
    Woods DC; Liu HK; Nishi Y; Yanase T; Johnson AL
    Cancer Lett; 2008 Feb; 260(1-2):20-7. PubMed ID: 18031928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid sensitizes K562 erythroleukemia cells to TRAIL/Apo2L-induced apoptosis.
    Iacomino G; Medici MC; Russo GL
    Anticancer Res; 2008; 28(2A):855-64. PubMed ID: 18507029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS; Mulherkar N; Prasad KV
    Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
    Sivaprasad U; Shankar E; Basu A
    Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.